A first-in-human trial of selective CDK7 inhibitor Q901, in patients with advanced solid tumors: Interim results of a phase I study (QRNT-009).

Wednesday, June 19, 2024

Dr. Minal Barve

Click the above link to view the abstract.

ASCO 2024 Poster for Trial 22-26

ASCO 2024 Poster for Trial 22-26